Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,230.12
(
0.29%
)
US TECH 100
26,942.00
(
0.87%
)
Dow Jones
49,499.27
(
-0.31%
)
Brent Oil
107.80
(
0.00%
)
Bitcoin
78,431.20
(
-0.32%
)
News Focus
News Focus
Post# of 824155
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

exwannabe

Send PM Follow Ignore
Followers 92
Posts 20563
Boards Moderated 0
Alias Born 09/06/2006

exwannabe

Re: Doc logic post# 818142

Tuesday, 03/17/2026 12:17:57 PM

Tuesday, March 17, 2026 12:17:57 PM

Post# of 824155

The ovarian cancer trial demonstrated some positive treatment


Did it?

The only results I see are these.

6 patients treated with a combination of:
. Bevacizumab (Avastin)
. cyclophosphamide (chemo)
. DCVax-L
. An autologous T cell vaccine

The 6 patients had 2 partial responses, which is not bad, but no way to know what they were caused by when it is a 4 drug combo.

I would also note that the sponsor, U Penn, continued on with DC vaccines trials but not with DCVax-L.. They used an alternative DC vaccine.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News